Segmed Activities
RSNA 2026
Segmed is at RSNA 2026 to show how real-world imaging data, connected to its clinical records, becomes research-ready multimodal cohorts and insights. Join our sessions, visit the booth, or book time with our team.
Real-World Multimodal Data,
Rooted in Imaging.
Segmed is a real-world data company built on imaging. We connect de-identified medical images with the clinical context around them, including EHR records, labs, medications, treatment history, and longitudinal outcomes, to build research-ready multimodal cohorts for AI developers, biopharma, and healthcare providers. Across our integrated partners, that means 12.5 million patients and 58.9 million imaging studies, with data that has supported 50+ FDA clearances.
At RSNA 2026, we’re bringing that work to the floor: new real-world research, a multimodal AI session with Verily Health, and booth talks on cohorts, imaging biomarkers, and foundation models. Book a meeting with our team.
Booth #5347
Stop at our booth by the AI Showcase Arena to meet the clinical, data, and business teams behind Segmed. Bring your question, whether you’re training and validating an AI model, building imaging evidence, or exploring what your institution’s imaging archive can support.
Monday through Wednesday join a 20-minute Real-World Talk at the booth.
Where to find us
Six sessions over four days, from peer-reviewed research to booth talks on multimodal cohorts, imaging biomarkers, and foundation models.
Temporal Trends In PI-RADS Adoption For Prostate MRI In Non-Academic Practice: A US Multicenter Real-World Analysis
PRISM: Breaking Real-World Data Into Ready-to-Use Multimodal Cohorts
Cutting-Edge Advances In Vascular Imaging
How To Use AI For Clinical Vascular Imaging
From Images To Lasting Clinical Impact: Real-World Data Across The Foundation Model Lifecycle
Beyond The Image: Unlocking Multimodal Data For Next Generation AI
Unlocking Imaging Biomarkers In GLP-1 Patients At Scale
Beyond The Image: Unlocking Multimodal Data For Next Generation AI
Martin Willemink, M.D., Ph.D., is a co-founder at Segmed and serves the company as Chief Scientific Officer. He is a physician, epidemiologist, biomedical engineer, scientist, and entrepreneur. Previously, Martin directed clinical cardiovascular imaging research at Stanford Radiology and served as CEO of Segmed.
Martin has published 100+ peer-reviewed papers, has been invited to present 60+ lectures at international scientific meetings, is a Fulbright laureate, and received funding from the American Heart Association, Philips Healthcare, Stanford University, and more. He is designated as a Fellow of the Society of Cardiovascular Computed Tomography (SCCT) and is an active member of multiple European and North American clinical scientific societies. His work has amongst others been recognized with awards from the Radiological Society of North America, European Society of Radiology, Society of Thoracic Radiology, and European Society of Thoracic Imaging.
Bharat Rajagopal is the Chief Revenue Officer at Verily Health where he leads the strategy and execution of commercial revenue generating activities, including sales, business development, partnerships and customer success to advance precision health. Previously, Bharat spent more than two decades at Microsoft, most recently serving as the General Manager of Microsoft’s U.S. Life Sciences and MedTech business. In this role, he led a team of sales, technical and operational leaders and partnered with pharma, medtech and life science organizations to advance their digital transformation efforts to bring life-saving therapies to market faster. Prior to that, Rajagopal served as Chief Operating Officer of Microsoft's Gulf Coast Enterprise & Partner Group, where he drove significant enterprise software growth by enabling digital transformation for global customers in high tech, oil and gas. Bharat holds an MS in Mechanical Engineering from The University of Toledo and an MBA from Northwestern University - Kellogg School of Management.
Artificial intelligence in medical imaging is rapidly evolving beyond image interpretation alone. The next generation of clinically impactful AI will depend on integrating medical images with a rich clinical context. This clinical context includes electronic health records (EHR), pathology, laboratory results, medications, and longitudinal outcomes. Yet accessing and harmonizing these multimodal data sources remains one of the greatest challenges for researchers and AI developers.
This session explores why multimodal real-world data is becoming essential for developing robust, clinically relevant AI models and highlights practical strategies for building research-ready datasets at scale. Dr. Martin Willemink from Segmed and Bharat Rajagopal from Verily Health will discuss how their complementary platforms help connect imaging with broader clinical data, enabling more comprehensive AI development. Attendees will gain insight into emerging multimodal AI applications, common data integration challenges, and how collaborative data ecosystems can accelerate the next generation of medical AI innovation.
Meet the Segmed
team at RSNA
We are ready to talk through the questions your data hasn’t answered yet. Visit our booth, or request a meeting.
Book
time with
our team
Tell us what you'd like to discuss and when you're available. Our team will follow up to confirm a time to meet at booth #5347, South Hall Level 3, AI Showcase.
